Over the past 15 years, many important technological advances have been made that provide us with the tools needed to develop new techniques to monitor biorecognition and interaction events on solid devices and in solution. Coupled with the ability to fabricate features on solid substrates with nanoscale precision, biosensing offers unprecedented opportunities for genetic screening and detection. 'Gene chips' featuring dense arrays of oligonucleotides have been successfully applied to problems in transcriptional profiling and single-nucleotide polymorphism (SNP) discovery, where massively parallel analysis is required 1 . However, because the fluorescence-based readout of these chips involves not only highly precise and expensive instrumentation but also sophisticated numerical algorithms to interpret the data, these methods have been generally limited to use in research laboratories.
Recently, an impressive number of inventive designs for DNA-based electrochemical sensing have appeared. These types of sensors combine nucleic acid layers with electrochemical transducers to produce a biosensor and promise to provide a simple, accurate and inexpensive platform for patient diagnosis. In this review, we include illustrative examples and compare and contrast these designs (see Table 1 ). We also discuss how these technologies might be implemented to produce sensitive multiplexed assays for clinical diagnostics of genetic and infectious disease. Several recent and comprehensive reviews have also been published [2] [3] [4] . Given the pace of advances in this field, the development of clinical and even point-of-care DNA diagnostics based on these technologies seems a realistic goal.
Principles of biosensor function
All molecular-based biosensors rely on highly specific recognition events to detect their target analytes. The essential role of the sensor is to provide a suitable platform that facilitates formation of the probetarget complex in such a way that the binding event triggers a usable signal for electronic readout. The minimal elements of any biosensor include a molecular recognition layer and a signal transducer that can be coupled to an appropriate readout device. DNA is especially well suited for biosensing applications, because the base-pairing interactions between complementary sequences are both specific and robust.
In a typical configuration, a single-stranded probe sequence is immobilized within the recognition layer, where base-pairing interactions recruit the target DNA to the surface (Fig. 1) . The repetitive, essentially uniform structure of DNA makes its assembly on the recognition surface well defined. It is at this interface that the critical dynamics of target capture take place to generate the recognition signal; therefore, immobilizing nucleic acid probe sequences in a predictable manner while maintaining their inherent affinity for target DNA is crucial to overall device performance. How this recognition event is reported depends ultimately on the method of signal transduction, whether it be optical, mechanical or electrochemical.
Optical readout. The use of photolabile protection schemes, coupled with photochemical screening techniques and combinatorial phosphoramidite chemistry, allows the fabrication of 'gene chips' for massively parallel detection of target DNA sequences 5 . Optical biosensors based on fluorescence are extraordinarily sensitive, with detection limits approaching ∼10 7 molecules/cm 2 , and arrays containing thousands of unique probe sequences have been constructed 6 . Because the instrumentation required is sophisticated and expensive, gene-chip technology is best suited for laboratory applications. Cases in which large numbers of genes or sequences need to be simultaneously sampled, as in transcriptional profiling or SNP discovery, are well suited to gene-chip analysis [7] [8] [9] [10] . Clinical diagnostics do not generally require this massive data accumulation. What is required for the molecular diagnostic, however, is reliability and generality irrespective of sequence. Besides the cost and sophistication of the instrumentation, the inconsistent yields of target synthesis and labeling, as well as nonuniform rates of fluorophore photobleaching can result in readout accuracies lower than what is required for patient diagnosis 11 .
Surface plasmon resonance (SPR), another optical technique, reports changes in the refractive index of a thin metal film substrate that occur upon adsorption of the analyte and is suitable for target detection in an array-based format 12 . To achieve detection limits sufficient for a diagnostically useful signal, it is usually necessary to amplify the hybridization signal by increasing the amount of material deposited at the metal film surface, either before or after target Electrochemistry-based sensors offer sensitivity, selectivity and low cost for the detection of selected DNA sequences or mutated genes associated with human disease. DNA-based electrochemical sensors exploit a range of different chemistries, but all take advantage of nanoscale interactions between the target in solution, the recognition layer and a solid electrode surface. Numerous approaches to electrochemical detection have been developed, including direct electrochemistry of DNA, electrochemistry at polymer-modified electrodes, electrochemistry of DNA-specific redox reporters, electrochemical amplifications with nanoparticles, and electrochemical devices based on DNA-mediated charge transport chemistry.
capture. Moreover, as with fluorescence-based techniques, SPR systems can be complex and costly (although the cost is decreasing), making them generally more suitable for research applications.
Perhaps the most straightforward optical readout technology involves single-stranded DNA labeled with gold nanoparticles that simply change color upon hybridization of the target sequences 13 . Using photographic silver developing solutions, a 'scanometric' smallarray platform for DNA analysis at a flatbed scanner has been demonstrated using this technology with 100-pM sensitivity 14 . This technology, offering simplicity and sensitivity, could provide a useful approach for clinical diagnostic development with optical readout.
Mass readout. An alternative readout strategy is to monitor mass changes in the immobilized recognition layer that occur upon target binding, most frequently using a quartz crystal microbalance (QCM) 15 . These devices are sensitive and can provide real-time monitoring of hybridization events. Although reliable operation of the QCM in aqueous solution has been a technical challenge, new amplification strategies may overcome this limitation 16 .
Changes in mass can also be measured using microfabricated cantilevers 17 . Here, the increase in mass that accompanies hybridization is detected by the deflection of a laser beam reflected from the cantilever surface. This technique is well suited for linear array development and provides continuous internal correction for nonspecific interactions and thermal drift. The primary limitations of microcantilever techniques again are the associated expensive instrumentation and the technical difficulties involved with fabricating the cantilever features.
Electrochemical readout. Electrochemical methods are well suited for DNA diagnostics. Because electrochemical reactions give an electronic signal directly, there is no need for expensive signal transduction equipment. Moreover, because immobilized probe sequences can be readily confined to a variety of electrode substrates, detection can be accomplished with an inexpensive electrochemical analyzer. Indeed, portable systems for clinical testing and on-site environmental monitoring are now being developed 18 . Sensitive electrochemical signaling strategies based on the direct or catalyzed oxidation of DNA bases, as well as the redox reactions of reporter molecules or enzymes recruited to the electrode surface by specific DNA probe- 
Figure 1
General DNA biosensor design. Target DNA is captured at the recognition layer, and the resulting hybridization signal is transduced into a usable electronic signal for display and analysis. In the case of electronic and electrochemical biosensors, signal transduction is greatly simplified, because the incoming signal is already electronic in origin. 
Direct electrochemistry of DNA as a detection platform
The earliest electrochemical DNA sensing strategy was based on reduction and oxidation of DNA at a mercury electrode; simply, the amount of DNA reduced or oxidized would reflect the amount of DNA captured. More than 40 years ago, Palecek 19 and co-workers developed methods to discriminate single-versus double-stranded DNA through direct DNA reduction. More recently, DNA oxidation has been carried out through adsorption stripping voltammetry (ASV) 20 . This technique achieves its high sensitivity by inducing an electrostatic buildup of analyte at the electrode surface before the detection step. The purine bases of DNA can be oxidized electrochemically, and this process can be carried out using carbon, gold, indium tin oxide (ITO) and polymer-coated electrodes 21 . Although this methodology is inherently quite sensitive, its application is complicated by significant background currents at the relatively high potentials required for direct DNA oxidation. Numerical methods to improve the signal-to-noise ratio have been developed, but more recent designs employ physical separation techniques to remove the sources of background interference. For example, Palecek and colleagues 22 and Wang and Kawde 23 have separately reported a two-step strategy for capturing target sequences using probe DNA immobilized onto magnetic beads. After target hybridization, the beads are magnetically separated from the pool of analytes. The collected DNA is depurinated in acidic solution, and the free guanine and adenine nucleosides are collected and analyzed using ASV. As few as 40 femtomoles (∼2 × 10 10 molecules) of substrate have been detected by this assay.
A similar technique using the direct guanine oxidation signal at carbon paste electrodes has recently been reported, in which specific genotypes of the Factor V Leiden mutation in PCR amplicons were identified 24 . The use of peptide nucleic acid probes 25 affords more stringent control over hybridization, and recent studies have shown that point mutations in target DNA can be more readily discerned using this methodology.
Indirect electrochemistry of DNA as a detection platform
Methods to oxidize target DNA indirectly through the use of electrochemical mediators have also been explored (Fig. 2 ). An especially attractive approach uses polypyridyl complexes of Ru(II) and Os(II) to mediate the electrochemical oxidation of guanine. For example, Yang and Thorp 26 have used this method to detect trinucleotide-repeat expansions, in which catalytic currents due to the oxidation of guanine residues immobilized within the target sequence show a linear dependence on the repeat number. This same technique has been coupled to a reverse transcription-PCR assay to monitor the overexpression of genes in tumor samples 27 . Experiments with model PCR products have shown that the sensitivity of this system extends down to 550 attomoles of target DNA (∼3 × 10 8 molecules).
A noteworthy coding method has also been reported using this approach 28 . In this strategy, chemically modified bases are incorporated into PCR products, and the resulting DNA is detected at an ITO electrode by catalytic oxidation of the modified base. Though remarkably sensitive, it is not clear whether this technique is well suited to clinical diagnostics. The ITO electrode material may or may not be amenable to microfabrication in a multiplexed configuration. Nonetheless, the methodology does provide high sensitivity without complex instrumentation through redox-mediated DNA oxidation. reporter molecules. Appearance of the characteristic electrochemical response of the redox reporter therefore signals the hybridization event 29, 30 . Using physical separation methods to isolate the labeled sequences, detection limits on the order of ∼10 10 molecules have been reported. A variation on this approach involves a three-component 'sandwich' assay, in which the redox label has been attached to a synthetic sequence specifically designed to bind an overhang portion of the probe-target complex 31 . This dual-hybridization approach eliminates the need to modify the target strand, whose function is to bring together the probe and labeled sequences. In one example, ferrocene-labeled reporter strands signal the presence of target DNA hybridized to thiolated probe sequences immobilized onto gold electrodes (Fig. 3a) . Incorporation of a second redox reporter (dimethylcarbamyl ferrocene), with an oxidation potential 170 mV more positive than the ferrocene analog, allows the detection of two targets simultaneously and without spatial separation, much like a multicolor fluorescence labeling assay 32 . Using AC voltammetry, the detection of 50 nM target concentrations and the identification of a GT single-base mismatch was accomplished.
DNA-specific redox indicator detection platforms
Colloidal gold nanoparticles have also been used to signal hybridization in a sandwichbased assay. In one study, the labeled target is captured by probe strands immobilized on a pencil graphite electrode, and hybridization is detected electrochemically with the appearance of a characteristic gold-oxidation signal 33 . The signal is greatly enhanced because of the large electrode surface area and the availability of many oxidizable gold atoms in each nanoparticle label. Indeed, the detection limit for PCR amplicons was found to be as low as 0.8 femtomoles of DNA (∼5 × 10 8 molecules).
Employing nanoparticle labels with different redox potentials, Wang et al. 34 have developed a technique in which these nanoparticles encode DNA sequences (Fig. 3b) . Probemodified magnetic beads are hybridized with target DNA, separated magnetically from the pool of analytes and hybridized again with the nanoparticle-labeled reporter strands. The products are isolated, and the nanoparticles are dissolved and analyzed by ASV. Electrochemical detection of three targets simultaneously was demonstrated with CdS, ZnS and PbS nanoparticle tags.
In yet another innovative application of this approach, Willner and Willner 35 have developed nanoparticle architectures of CdS particles and DNA to provide photoelectrochemical detection of DNA hybridization. Immobilized probe DNA is hybridized to target DNA, which is subsequently hybridized with a CdS-labeled reporter strand. This CdS-DNA aggregate can be further elaborated by repetitive treatment of oligonucleotide-modified nanoparticles and complementary bridging DNA strands to produce larger assemblies of the nanoparticle labels. Exposure of this aggregate to visible blue light triggers a photoelectrochemical current between the CdS nanoparticle aggregate and the gold electrode.
Many applications of DNA sensing (for example, real-time pathogen detection) involve extremely small numbers of target analytes, with correspondingly few hybridization events. Analyte amplification has also been accomplished in an innovative way indirectly using electrochemical detection of nanoparticles (Box 1).
In an effort to improve transduction of the hybridization signal, an electrode surface may also be modified with a polymer layer that confers desirable properties, such as electrical conductivity, amenability to probe immobilization or protection of the electrode from nonspecific analyte adsorption. Heller and colleagues 36 have reported an enzyme-amplified DNA sensing technique involving the electropolymerization of a polycationic redox polymer, upon which amineterminated oligonucleotide single strands are electrodeposited by ligand exchange with bipyridyl osmium complexes impregnated within the polymer gel. Target DNA is captured at the electrode surface and subsequently hybridized to a reporter strand modified with HRP. This technique has been extended to screen-printed carbon electrodes on polyester sheets, which are inexpensive and potentially amenable to mass manufacture 37 .
Biocatalyzed production of insoluble products has been used by Willner and colleagues 38 to sense DNA hybridization electrochemically at probe-modified electrodes. Target DNA is captured at a probemodified gold electrode, where a redox-active DNA intercalator electrocatalytically generates peroxide, which, in turn, is oxidized by Figure 5 Electrochemical assay for mismatches through DNA-mediated charge transport. On the right is shown an electrode modified with well-matched duplex DNA. Current flows through the well-stacked DNA to reduce methylene blue (MB + ) intercalated near the top of the film, to leucomethylene blue (LB). LB goes on to reduce ferricyanide in solution, thereby regenerating MB + catalytically, leading to an amplification of the hybridization signal. In the case of a DNA film containing mismatched duplexes (left), current flow through the DNA duplex is attenuated, MB + is not reduced, and the catalytic signal is lost. Figure 4 Scheme for an enzymatic amplification of DNA hybridization signal. DNA probes are immobilized onto the electrode surface. Target DNA is pretreated with enzyme-modified probe, which binds the 5′ end of the target. The target-enzyme complex is hybridized to the probe, and the biocatalyzed precipitation of product dimer provides amplification of the hybridization signal, which is detected as an increase in electron transfer resistance between the electrode and ferricyanide in solution. Adapted from ref. 45. horseradish peroxidase (HRP). The product precipitates onto the electrode, blocking the reaction of ferricyanide and providing the basis for DNA detection. In a variation on this approach, 5-bromo-4-chloro-3-indoyl phosphate is enzymatically converted to an insoluble indigo product, blocking ferricyanide; using this method, the detection limit for target DNA was extended down to 5 × 10 -14 M (Fig. 4) 39 . An enzyme-based hybridization assay for detection of two DNA targets has also been described in which alkaline phosphatase and β-galactosidase are used to differentiate between two DNA targets by measuring the chronopotentiometry of their electroactive products 40 . These products yield well-resolved oxidation signals at carbon electrodes to allow amplified dual-target electrochemical detection.
DNA-mediated charge transport electrochemistry
In an alternative approach to chemical labeling schemes, redox-active reporter molecules that intrinsically associate with the double helix noncovalently have been successfully used for electrochemically based DNA analysis. In these analyses, rather than serving as a reactant, the DNA is the mediator. These assays can provide high sensitivity and simplicity.
Electrostatic probe molecules. The notion that electrochemical reactions could be used to signal DNA hybridization was first explored by Milan and Mikkelsen 41 . Their assay featured a single-stranded probe sequence adsorbed onto glassy carbon, wherein hybridization of target DNA caused an increase in the surface concentration of electrostatically bound Co(phen) 3 3+ as a result of the higher negative charge density at the hybridized surface. Characteristic redox reactions of the cobalt probe provided the electrochemical readout. More recently, Steel et al. 42 reported the effective use of Ru(NH 3 ) 6 3+ probe molecules to signal DNA hybridization at gold films modified with thiol-bearing DNA probe sequences. As the DNA is captured to form doublestranded product, proportionately more ruthenium hexammine binds, yielding a higher signal. It is noteworthy how simple and quantitative this redox reporter is, providing a reliable and robust assay for the amount of DNA present on the electrode surface.
Intercalative probe molecules. Our work in this field has taken advantage of the electronic structure of double-helical DNA, using intercalated redox probe molecules to report on perturbations in base stacking 43 . The intercalator is thus not used in this assay to report the amount of DNA or whether it is double stranded versus single stranded. Instead, the DNA base pair stack mediates charge transport to the intercalator bound at the top of the film. If the base pair stack is intact, current can flow. Therefore, we take advantage of a different inherent characteristic of duplex DNA, its ability to mediate charge transport. We have found this chemistry to be exquisitely sensitive to DNA structure and perturbations in structure. Assays of DNA-mediated electrochemistry are therefore uniquely suited to sense changes in DNA: damage, mistakes, mismatches and even protein binding.
In a typical assay, thiolated duplexes are self-assembled into densely packed films on gold surfaces, then treated with micromolar concentrations of a redox-active intercalator 44 . Upon intercalation, the reporter molecule is electrochemically reduced by DNA-mediated charge transport. Importantly, the reaction occurs only if the individual duplexes in the film contain well-stacked base pairs; the presence of just a single intervening mismatch is sufficient to shut off the reaction completely 45 . Because of its remarkable specificity to the electronic structure of the π-stack, this assay is especially well suited for mutational analysis 46 . The detection of mismatches does not depend on the thermodynamic destabilization at a mismatch site; rather, it depends on the change in base stacking that alters current flow. The need for stringent hybridization control to distinguish between matched and mismatched sequences near their melting temperature is therefore completely eliminated. The assay is carried out using DNA films wherein the DNA, matched or mismatched, is in the duplex form, irrespective of melting temperature or sequence.
To increase the inherent sensitivity of the assay, we have developed a coulometric readout strategy based on the electrocatalytic reduction of ferricyanide by methylene blue 47 . In the electrocatalytic process, electrons flow from the electrode surface to intercalated methylene blue in a DNA-mediated reaction. The reduced form of methylene b a Figure 6 Electrochemically based DNA sensors for protein analytes. (a) DNA-modified electrodes to monitor pap of the film. Proteins (brown) that kink the DNA or flip a base out, perturbing the base pair stack, interrupt current flow to daunomycin, attenuating the redox signal. The remaining exposed gold electrode surface is backfilled with mercaptohexanol (gray) to prevent daunomycin or protein from interacting directly with the electrode. (b) Scheme (left) for the electrochemical analysis of DNA restriction kinetics at a DNA-modified electrode. Current flows through the DNA to daunomycin (red) bound near the top of the film, and daunomycin reduction is monitored electrically. Reaction on DNA by a restriction enzyme cleaves the duplex, releasing the daunomycin probe, causing a loss in signal. Shown also (right) is a representation of the electrode response (blue) through the DNA restriction process. This assay provides real-time analysis of the enzyme kinetics on DNA.
blue then reduces ferricyanide in solution, so that additional electrons can flow to methylene blue and the DNA base stack is repeatedly interrogated. If the DNA contains a mismatch, the bound methylene blue is not catalytically active and the electrochemical signal is greatly diminished. Using this assay (Fig. 5) , all of the possible single-base mismatches (including the thermodynamically stable GA mismatch) have been readily detected 46 . The reaction has also been carried out on an addressable 18-electrode array featuring microelectrode gold pads. At a 30-µm electrode, as few as ∼10 8 duplexes have been detected. Thus DNA-mediated charge transport provides specificity in mutation detection, sensitivity through electrocatalysis, facile access to an array format, and a wholly different approach to DNA sensing electrically.
Detecting proteins and small molecules bound to DNA Given all these innovative strategies for sensing DNA electrochemically, can a DNA-based sensor be used to assay molecules that bind to DNA or react with it? DNA, because of its general structural uniformity, is reliably assembled on an electrode surface, essentially independently of sequence or length. The same cannot be said about other analytes of interest, with proteins the most obvious example. Thus, different laboratories are beginning also to take advantage of the ease of DNA sensor design in developing assays for proteins and small molecules that bind to DNA. One illustration, recently described, is an electrochemical DNAbased sensor for the detection of arsenic trioxide 48 . In this example, the voltammetric signal, reflecting direct guanine oxidation, decreases with exposure time and concentration of As 2 O 3 , presumably as a result of a reaction between guanine and arsenic trioxide that damages purine bases. Although other contaminants can also interfere through their preferential reaction with DNA, it is the detection of molecules that bind irreversibly to DNA in the environment that is of interest. Thus, this strategy may provide the basis for a range of sensitive environmental sensors. Currently, using PCR for biochemical amplification, coupled with a redox-label probe assay, a portable sensor to analyze for anthrax is being developed 49 .
We have taken advantage of DNA-mediated charge transport chemistry to assay for protein binding and reaction electrically 50 . In this study, duplex DNA containing a protein binding site is covalently modified with daunomycin, an electroactive intercalator, and assembled in a loosely packed monolayer onto a gold surface. Mercaptohexanol to backfill the monolayer prevents direct interaction between the daunomycin probe and the electrode surface. Upon exposure of the DNAmodified electrode to a solution of M.HhaI, a base-flipping enzyme, the
Box 1 Amplification strategies with nanoparticles
The deposition of silver metal onto gold nanoparticles exemplifies the ability of electrochemical methods to amplify the electrical signal. In a typical approach, a sandwich assay is carried out to recruit gold nanoparticles to a magnetic bead by means of the target DNA. Once mechanically separated, the chimeric duplexes are treated with a silver developing solution (silver ions and hydroquinone) to deposit silver metal onto the gold labels 53, 54 . An acid treatment to redissolve the silver and subsequent ASV of the adsorbed metal ions extends the detection limits down to 1.5 femtomole, or ∼9 × 10 8 molecules, in a 50-µl hybridization solution 55 .
Mirkin and colleagues 56 have exploited the silver deposition technique to construct a sensor based on conductivity measurements (Fig. 7) . In their approach, a small array of microelectrodes with gaps (20 µm) between the electrode leads is constructed, and probe sequences are immobilized on the substrate between the gaps. Using a three-component sandwich approach, hybridized target DNA is used to recruit gold nanoparticle-tagged reporter strands between the electrode leads. The nanoparticle labels are then developed in the silver enhancer solution, leading to the precipitation of silver metal onto the gold nanoparticles. The deposition of silver closes the electrical connection between the two flanking microelectrodes, and target capture is signaled by a sharp drop in the resistance of the circuit. This technique demonstrated a sensitivity of ∼5 × 10 -13 M in target DNA. An unusual dependence of hybridization stringency based on salt concentration, probably involving the cooperative interactions among targets on the nanoparticle, allows excellent discrimination of single-base mutations within the target sequences.
Another improvement in sensitivity has been reported for a sandwich assay in which the gold nanoparticles are replaced with polystyrene microsphere tags impregnated with ferrocenecarboxaldehyde (FCA) 57 . Because each microsphere contains on the order of 10 11 FCA molecules, capture and subsequent dissolution of the polystyrene shell in acetonitrile to liberate the FCA for electrochemical quantification results in an enormous amplification of the hybridization event. This technique has a demonstrated detection limit of 5 × 10 -21 moles (or ∼30,000 molecules), the record thus far. daunomycin redox signal is greatly attenuated, indicating that protein binding disrupts the integrity of the base stack because of base flipping. When a K237W mutant HhaI enzyme is used instead, a tryptophan residue is inserted into the vacant site after base flipping, restoring both the π-stack and the daunomycin signal. When the electrochemical assay is used to detect TATA-binding protein (TBP), a transcriptional activator that kinks DNA, TBP binding is associated with substantial diminution in current flow through the DNA electrode. Thus, the DNA surface provides a sensitive way to assay for a variety of proteins (Fig. 6a ). An extension of this assay could be developed to screen for small-molecule inhibitors of transcription factor binding.
In the same study, we also presented a real-time electrochemical analysis of the kinetics of an enzyme, R.PvuII, restricting DNA; the signal from the chronocoulometry of daunomycin is diminished as the enzyme cleaves away the portion of DNA containing the redox label (Fig. 6b) . Comparison of the electrochemical data to an analogous gel electrophoresis experiment shows good agreement between the measured kinetics of DNA restriction. The assay, unlike gel electrophoresis, however, provides a basis for real-time monitoring of protein reactions on DNA as well as a foundation for developing sensitive electrical screening assays in an array format for small molecules that interfere with protein binding or reaction.
Conclusions and perspectives
Despite the enormous opportunities clearly offered by electrochemical DNA sensing, some important hurdles remain. The first depends upon the electrode probes themselves and their fabrication into useful arrays. Array sizes on the order of 10 have thus far been demonstrated, but more typically arrays of 50-100 sequences will be needed for clinical application. For example, genetic screening for cystic fibrosis carriers requires testing for 25 different mutations plus positive and negative controls 51 . Although it is not difficult to fashion electrode pads with reproducible dimensions of a micron or less, the electrochemical readout requires mechanical connections to each individual electrode. The construction of very large, multiplexed arrays (on the order of 10 3 ) therefore presents a major engineering challenge. Electronic switches in the form of an on-chip electronic multiplexer may provide a possible solution for this problem.
Another challenge that requires attention involves the biological complexity of a genomic DNA sample. Thus far, even with the high level of sensitivity one can achieve through electrochemical amplification, assays routinely start with a round of PCR or other biochemical amplification. Without this biochemical preamplification, low copy numbers present particular challenges for interfacial hybridization and lead to slow associated kinetics. Moreover, there is inherent complexity associated with the biological sample itself, before DNA isolation and purification. The real goal, for pathogen detection specifically, is an assay involving rapid DNA isolation with the detection of few copies in half an hour or less. With electrochemical sensors this goal is realizable, but we are not yet there.
The application of sensors to assaying of the proteome is a problem of even greater complexity. There is a tremendous need for highthroughput protein screening to catalog the human proteome in its biologically active form. Can the techniques and methodologies developed for DNA-based electrodes be extended to proteins? The irregular shapes, sizes, variety of post-translational modifications and general functional characteristics of proteins add many more dimensions of complexity. The wiring up of proteins to electrode surfaces for diagnostic and even screening applications is in its infancy 52 , but the lessons being learned through DNA electrodes, if not reactions mediated by DNA itself, should provide useful starting points.
Converting genomic information to clinical advantage can be successfully accomplished with DNA-based sensors. Their low cost, small size and inherent sensitivity will certainly provide important new tools for the diagnosis of disease.
